Get the Stockscreener App
10.55
1.34%
0.14
After Hours:
10.46
-0.09
-0.85%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $10.55, with a volume of 8.62M.
It is up +1.34% in the last 24 hours and up +14.80% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$10.41
Open:
$10.41
24h Volume:
8.62M
Relative Volume:
0.76
Market Cap:
$12.30B
Revenue:
$14.33B
Net Income/Loss:
$-3.79B
P/E Ratio:
-3.3281
EPS:
-3.17
Net Cash Flow:
$1.84B
1W Performance:
-0.94%
1M Performance:
+14.80%
6M Performance:
+10.70%
1Y Performance:
-11.27%
1-Day Range:
$10.40
$10.57
1-Week Range:
$10.23
$10.65
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.55 | 12.14B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
156.40 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 47.28B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 43.41B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 20.69B | 16.70B | -157.13M | 1.19B | -0.155 |
|
NBIX
Neurocrine Biosciences Inc
|
139.60 | 13.78B | 2.41B | 305.80M | 492.20M | 2.95 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-25 | Initiated | Goldman | Neutral |
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
Epinephrine Market to Size to Reach USD 5.74 Billion by 2032 as Demand for Emergency Allergy Treatments Surges – SNS Insider - GlobeNewswire Inc.
Stock Analysis | Viatris OutlookA Stock to Watch Closely Amid Mixed Signals - AInvest
Using economic indicators to assess Viatris Inc. potentialMarket Trend Report & High Return Trade Guides - Newser
Published on: 2025-09-01 02:39:21 - Newser
Advanced analytics toolkit walkthrough for Viatris Inc.Forecast Cut & Low Drawdown Momentum Trade Ideas - Newser
Why Viatris Inc. stock attracts strong analyst attentionMarket Weekly Review & Low Risk Growth Stock Ideas - Newser
Risk adjusted return profile for Viatris Inc. analyzed2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
What to expect from Viatris Inc. in the next 30 days2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Analyzing recovery setups for Viatris Inc. investorsJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - Newser
Should you hold or exit Viatris Inc. nowIPO Watch & Fast Moving Market Watchlists - Newser
How to use a screener to detect Viatris Inc. breakoutsWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
How to use Fibonacci retracement on Viatris Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Statistical indicators supporting Viatris Inc.’s strengthSell Signal & Growth Focused Entry Reports - Newser
Published on: 2025-08-31 00:24:18 - Newser
Evaluating Viatris Inc. with trendline analysisWeekly Stock Recap & Low Drawdown Momentum Ideas - Newser
Using data tools to time your Viatris Inc. exitJuly 2025 Institutional & Verified Swing Trading Watchlist - Newser
Using Bollinger Bands to evaluate Viatris Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Can Viatris Inc. recover in the next quarterJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Published on: 2025-08-30 20:54:29 - Newser
Using fundamentals and technicals on Viatris Inc.July 2025 EndofMonth & Reliable Trade Execution Plans - Newser
Combining machine learning predictions for Viatris Inc.Earnings Risk Report & AI Driven Stock Reports - Newser
Key resistance and support levels for Viatris Inc.Weekly Stock Report & Daily Profit Maximizing Tips - Newser
Will Viatris’ (VTRS) New Transformation Role Accelerate Its Operational and Cultural Overhaul? - Yahoo Finance
Full technical analysis of Viatris Inc. stock2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Applying Wyckoff theory to Viatris Inc. stockWeekly Trade Report & Community Shared Stock Ideas - Newser
Published on: 2025-08-29 22:33:39 - Newser
Using data models to predict Viatris Inc. stock movementPortfolio Value Report & Stock Portfolio Risk Control - Newser
Sentiment analysis tools applied to Viatris Inc.Earnings Risk Summary & Safe Entry Zone Tips - Newser
Published on: 2025-08-29 13:16:28 - Newser
Viatris, Inc. (VTRS) Achieves Key Clinical Milestones in Ophthalmology, Pain, Women’s Health - Insider Monkey
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):